The store will not work correctly when cookies are disabled.
3-Heptyl-5-[2-(5-methoxy-1H-indol-3-yl)ethyl]-1,3,4-oxadiazol-2(3H)-one
ID: ALA4787595
PubChem CID: 162667374
Max Phase: Preclinical
Molecular Formula: C20H27N3O3
Molecular Weight: 357.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCn1nc(CCc2c[nH]c3ccc(OC)cc23)oc1=O
Standard InChI: InChI=1S/C20H27N3O3/c1-3-4-5-6-7-12-23-20(24)26-19(22-23)11-8-15-14-21-18-10-9-16(25-2)13-17(15)18/h9-10,13-14,21H,3-8,11-12H2,1-2H3
Standard InChI Key: BXNOYMDUUOYKFD-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
37.9691 -5.5222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9679 -6.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6760 -6.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6742 -5.1133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3828 -5.5186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3831 -6.3372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1617 -6.5900 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.6428 -5.9275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1613 -5.2654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2613 -5.1138 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.5537 -5.5225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4136 -4.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2128 -4.3180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4651 -3.5407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2392 -3.2894 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.2389 -2.4722 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.4616 -2.2199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9816 -2.8813 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.2088 -1.4429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.8999 -1.9917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6466 -2.3238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3075 -1.8432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0542 -2.1754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.7151 -1.6948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.4618 -2.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.1227 -1.5464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 1 0
10 11 1 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
17 19 2 0
16 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 357.45 | Molecular Weight (Monoisotopic): 357.2052 | AlogP: 4.08 | #Rotatable Bonds: 10 |
Polar Surface Area: 73.05 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.91 | CX LogD: 4.91 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -0.73 |
References
1. Herrera-Arozamena C,Estrada-Valencia M,Pérez C,Lagartera L,Morales-García JA,Pérez-Castillo A,Franco-Gonzalez JF,Michalska P,Duarte P,León R,López MG,Mills A,Gago F,García-Yagüe ÁJ,Fernández-Ginés R,Cuadrado A,Rodríguez-Franco MI. (2020) Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties., 190 [PMID:32018096] [10.1016/j.ejmech.2020.112090] |